Nu-Med Plus, Inc. (OTCPK:NUMD) entered into a letter of intent to acquire Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner on May 15, 2023. Nu-Med Plus shall issue up to 600,000 shares of Preferred Stock to the holders of the Merging Entity's capital stock (the "Merger Consideration"). Nu-Med Plus will assume all liabilities of the Merging Entity, including any liabilities arising after the Closing Date under any assigned contracts of the Merging Entity. The consummation of the Transaction is subject to due diligence, the negotiation and the execution of the Definitive Agreement, including exhibits and schedules thereto, in form and substance satisfactory to each of the Merging Entity, the Surviving Entity and their respective counsel. Nu-Med Plus will require its stockholders to enter into a lock-up agreement with respect to its common stock for a period of not less than 180 days from the date of closing upon the merger. Nu-Med Plus, Inc. and its stockholders will be required to comply Rule 144 promulgated by the Securities and Exchange Commission. Nu-Med Plus, Inc. (OTCPK:NUMD) entered into a Share Exchange Agreement to acquire Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner on April 25, 2024. Upon the Closing of the Transaction, YourSpace America, Inc. will become a wholly owned subsidiary of the Nu-Med Plus, Inc. Under the terms of the Share Exchange Agreement, the Shareholders of YourSpace America, Inc. have agreed to sell 100% of the issued and outstanding shares of YourSpace America, Inc. to Nu-Med Plus, Inc. in exchange for the issuance of the Nu-Med Plus, Inc.?s Series A Preferred Stock, and Series X Preferred Stock, as follows:
4,500,000 shares of Series A Preferred Stock will be issued to such YourSpace America, Inc. Shareholders as designated by YourSpace America, Inc. at Closing. 1,000,000 shares of Series X Preferred Stock will be issued to YourSpace America, Inc.?s President, Chief Executive Officer and Chief Investment Officer, William R. Colvin at Closing. Additionally, upon the Closing, the Board of Directors of the Nu-Med Plus, Inc. will appoint Mr. Colvin as the Nu-Med Plus, Inc.?s President, Chief Executive Officer, and Director, at which time William Hayde shall be appointed Executive Chairman of the Board. Keith Merrell will continue to serve as the Nu-Med Plus, Inc.?s Chief Financial Officer and Director, and Jeffrey Robins will continue to serve as Director. Both the board of directors of the Nu-Med Plus, Inc. and of YourSpace have each determined that it is desirable and in the best interests of the Shareholders of their respective companies to affect the Share Exchange.